Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

658
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
658

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Virome-wide ubiquitin ligase discovery reveals diverse mechanisms of immune evasion.

Science (New York, N.Y.)·2026
Same author

A viral ORFeome library for systems-level genetic dissection of host-pathogen interactions.

Cell·2026
Same author

Persistence of memory: lifespan dynamics of the human antiviral antibody reactome.

Nature communications·2026
Same author

Systems-Scale Structural Modeling Reveals the Germline Architecture of Immunodominance.

bioRxiv : the preprint server for biology·2026
Same author

Integrative Molecular Analyses of Inflammatory and Autoimmune Signals in Cardiac Sarcoidosis.

Circulation·2026
Same author

A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines.

Nature immunology·2026

相关实验视频

Updated: Jun 5, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

125

T-Switch:一个基于特异性的工程平台,用于开发安全有效的T细胞疗法.

Nouran S Abdelfattah1, Tomasz Kula1, Stephen J Elledge1

  • 1Department of Genetics, Harvard Medical School, Division of Genetics, Brigham and Women's Hospital, Howard Hughes Medical Institute, 77 Avenue Louis Pasteur, Boston, MA 02115, USA.

Immunity
|December 4, 2024
PubMed
概括
此摘要是机器生成的。

一个名为T-Switch的新平台设计T细胞受体 (TCR),以准采用T细胞疗法 (ACT) 的自我抗原. 这种方法绕过了自然的耐受性,为癌症治疗创造了强效和安全的T细胞疗法.

关键词:
在T细胞,T细胞.在TCR演变过程中,TCR的演变.标本特异性的特异性自己反应的自我反应性.

更多相关视频

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.0K
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.2K

相关实验视频

Last Updated: Jun 5, 2025

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

125
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
14:23

Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells

Published on: April 16, 2012

24.0K
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants
10:44

A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants

Published on: August 9, 2019

7.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 生物技术是生物技术.
  • 在瘤学瘤学.

背景情况:

  • 采用T细胞疗法 (ACT) 面临的挑战是由于T细胞耐受机制,针对自我抗原.
  • 自反应性T细胞通常被消除或成为调节性,限制它们对自我抗原的治疗用途.
  • 开发安全向瘤相关自身抗原的T细胞疗法对于癌症治疗至关重要.

研究的目的:

  • 开发一个体外平台,T-Switch,用于设计能够准自我抗原的T细胞受体 (TCR).
  • 创建,修改和描述合成TCRs用于增强的T细胞基础免疫疗法.
  • 通过克服T细胞对自身抗原的耐受性来产生强效和安全的T细胞疗法.

主要方法:

  • 该T-Switch平台扩展T细胞识别外来抗原.
  • 定向进化修改了TCR的结区,将特异性转换为目标自我抗原.
  • 工程TCR的特异性和潜在的目标外影响被全面分析.

主要成果:

  • 使用T-Switch成功设计了针对瘤相关自身抗原的合成TCR.
  • 工程TCR的安全性和有效性在体外得到了验证.
  • 对人类蛋白质组进行了广泛的选,没有发现可检测的目标外识别.

结论:

  • T-Switch是一个有效的平台,用于生成高度特定的合成TCRs来对抗自我抗原.
  • 这种方法提供了一种可行的策略,可以绕过T细胞耐受性,用于开发新型癌症免疫疗法.
  • 工程TCR有望创造下一代基于T细胞的疗法,以提高安全性和有效性.